Trexquant Investment’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-53,804
Closed -$1.6M 1818
2024
Q1
$1.6M Buy
53,804
+43,112
+403% +$1.35M 0.03% 734
2023
Q4
$342K Buy
+10,692
New +$310K 0.01% 1212
2023
Q3
Sell
-110,239
Closed -$4.96M 1786
2023
Q2
$4.96M Sell
110,239
-30,826
-22% -$1.18M 0.13% 211
2023
Q1
$4.86M Buy
141,065
+99,586
+240% +$3.23M 0.13% 198
2022
Q4
$1.16M Buy
+41,479
New +$1.1M 0.03% 600
2021
Q2
Sell
-13,221
Closed -$585K 1463
2021
Q1
$585K Sell
13,221
-379
-3% -$14.1K 0.05% 452
2020
Q4
$395K Buy
13,600
+775
+6% +$19.3K 0.04% 541
2020
Q3
$281K Buy
+12,825
New +$228K 0.02% 942
2020
Q1
Sell
-27,023
Closed -$423K 1382
2019
Q4
$423K Buy
+27,023
New +$307K 0.03% 619
2016
Q3
Sell
-21,177
Closed -$379K 978
2016
Q2
$379K Buy
+21,177
New +$315K 0.05% 575

Other funds holding SGRY

Trexquant Investment's SGRY Position: Q2 2024 in Review

Trexquant Investment sold out of Surgery Partners (SGRY) in Q2 2024, closing a stake of 53,804 shares — an estimated $1.6M sold.

Trexquant Investment first reported a position in SGRY in Q2 2016 and held it in 10 quarters. The position peaked at $4.96M in Q2 2023. 179 funds tracked by Wall St. Rank hold SGRY as of Q2 2024.

  • Trexquant Investment reported no remaining Surgery Partners position as of Q2 2024 after selling out during the quarter.
  • Trexquant Investment sold 53,804 Surgery Partners shares in Q2 2024, an estimated $1.6M.
  • Trexquant Investment first reported a position in Surgery Partners in Q2 2016 and held it in 10 quarters.
  • Trexquant Investment's Surgery Partners position peaked at $4.96M in Q2 2023.
  • 179 funds tracked by Wall St. Rank held Surgery Partners as of Q2 2024.

Based on Trexquant Investment's 13F filing for Q2 2024, filed 13 Aug 2024.